There is significant interest in using gene expression measurements to aid in the personalization of medical treatment. The presence of significant normal tissue contamination in tumor samples makes it difficult to use tumor expression measurements to predict clinical variables and treatment response. I present a probabilistic method, TMMpure, to infer the expression profile of the cancerous tissue using a modified topic model that contains a hierarchical Dirichlet process prior on the cancer profiles. I demonstrate that TMMpure is able to infer the expression profile of cancerous tissue and improves the power of predictive models for clinical variables using expression profiles.MAS
Malignant tumors remain one of the leading causes of mortality with over 8.2 million deaths worldwid...
Despite the individually different molecular alterations in tumors, the malignancy associated biolog...
Copyright © 2013 Keita Mori et al. This is an open access article distributed under the Creative Com...
Tumor heterogeneity is a limiting factor in cancer treatment and in the discovery of biomarkers to p...
Abstract Tumor heterogeneity is a limiting factor in cancer treatment and in the disco...
Motivation: Tissue Microarrays (TMAs) quantify tissue-specific protein expression of cancer biomarke...
We have developed a complete statistical model for the analysis of tumor specific gene expression pr...
Emergent molecular measurement methods, such as DNA microarray, qRTPCR, andmany others, offer tremen...
Gene expression profiles are some of the most abundant sources of data about the cellular state of a...
The tumor microenvironment is composed of tumor cells, stroma cells, immune cells, blood vessels, an...
Genome-wide measurement of gene expression is a promising approach to the identification of subclass...
Tumor cell lines are relied upon extensively for cancer investigations, yet cultured cells in an in ...
Infiltrating stromal and immune cells form the major fraction of normal cells in tumour tissue and n...
This PhD thesis studies dimensionality reduction using independent component analysis as a methodolo...
Tumor tissue samples comprise a mixture of cancerous and surrounding normal cells. Investigating cel...
Malignant tumors remain one of the leading causes of mortality with over 8.2 million deaths worldwid...
Despite the individually different molecular alterations in tumors, the malignancy associated biolog...
Copyright © 2013 Keita Mori et al. This is an open access article distributed under the Creative Com...
Tumor heterogeneity is a limiting factor in cancer treatment and in the discovery of biomarkers to p...
Abstract Tumor heterogeneity is a limiting factor in cancer treatment and in the disco...
Motivation: Tissue Microarrays (TMAs) quantify tissue-specific protein expression of cancer biomarke...
We have developed a complete statistical model for the analysis of tumor specific gene expression pr...
Emergent molecular measurement methods, such as DNA microarray, qRTPCR, andmany others, offer tremen...
Gene expression profiles are some of the most abundant sources of data about the cellular state of a...
The tumor microenvironment is composed of tumor cells, stroma cells, immune cells, blood vessels, an...
Genome-wide measurement of gene expression is a promising approach to the identification of subclass...
Tumor cell lines are relied upon extensively for cancer investigations, yet cultured cells in an in ...
Infiltrating stromal and immune cells form the major fraction of normal cells in tumour tissue and n...
This PhD thesis studies dimensionality reduction using independent component analysis as a methodolo...
Tumor tissue samples comprise a mixture of cancerous and surrounding normal cells. Investigating cel...
Malignant tumors remain one of the leading causes of mortality with over 8.2 million deaths worldwid...
Despite the individually different molecular alterations in tumors, the malignancy associated biolog...
Copyright © 2013 Keita Mori et al. This is an open access article distributed under the Creative Com...